News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as ...
Insurance coverage typically follows federal recommendations, so anyone who is healthy and under 65 is likely to have to pay ...
While RFK Jr. said the coronavirus vaccine would be removed from the CDC schedule for healthy children, it’s still ...
Today, the COVID vaccine for healthy children and healthy pregnant women has been removed from @CDCgov recommended immunization schedule. Bottom line: it’s common sense and it’s good science. We are ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
FDA commissioner Marty Makary joins "Face the Nation with Margaret Brennan" to discuss new COVID vaccination recommendations.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback